<?xml version="1.0" encoding="UTF-8"?>
<ref id="B50-biomolecules-10-01505">
 <label>50.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hevener</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Verstak</surname>
    <given-names>T.A.</given-names>
   </name>
   <name>
    <surname>Lutat</surname>
    <given-names>K.E.</given-names>
   </name>
   <name>
    <surname>Riggsbee</surname>
    <given-names>D.L.</given-names>
   </name>
   <name>
    <surname>Mooney</surname>
    <given-names>J.W.</given-names>
   </name>
  </person-group>
  <article-title>Recent developments in topoisomerase-targeted cancer chemotherapy</article-title>
  <source>Acta Pharm. Sin. B</source>
  <year>2018</year>
  <volume>8</volume>
  <fpage>844</fpage>
  <lpage>861</lpage>
  <pub-id pub-id-type="doi">10.1016/j.apsb.2018.07.008</pub-id>
  <pub-id pub-id-type="pmid">30505655</pub-id>
 </element-citation>
</ref>
